Web Results

Sorafenib - Wikipedia

en.wikipedia.org/wiki/Sorafenib

Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer ...

Sorafenib (Nexavar) Chemotherapy Drug Information - Chemocare

chemocare.com/chemotherapy/drug-info/Sorafenib.aspx

Sorafenib (Nexavar) side effects, what it's used for, how it's given, how it works, drug type, precautions and self care tips.

Sorafenib (Nexavar) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/sorafenib

Apr 29, 2015 ... Read about the cancer treatment drug sorafenib, otherwise known as Nexavar, including what it is, how it works and possible side effects.

FDA Approval for Sorafenib Tosylate - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/fda-sorafenib-tosylate

Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...

Nexavar (sorafenib) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com/nexavar.html

You should not use Nexavar if you are allergic to sorafenib, or if you have squamous cell lung cancer and you are being treated with carboplatin ( Paraplatin) and ...

Sorafenib: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/sorafenib.html

Easy to read patient leaflet for sorafenib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Sorafenib: a review of its use in advanced hepatocellular carcinoma.

www.ncbi.nlm.nih.gov/pubmed/19228077

Sorafenib (Nexavar) is an orally active multikinase inhibitor that is approved in the EU for the treatment of hepatocellular carcinoma. Monotherapy with sorafenib  ...

Sorafenib (Nexavar®) | OncoLink

www.oncolink.org/cancer-treatment/chemotherapy/oncolink-rx/sorafenib-nexavar-r

Jan 13, 2016 ... Sorafenib (Nexavar®) is an oral multikinase inhibitor used in the treatment of liver , kidney and thyroid cancers.

Sorafenib | C21H16ClF3N4O3 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/Sorafenib

Sorafenib is a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the ...

Sorafenib in Advanced Hepatocellular Carcinoma — NEJM

www.nejm.org/doi/full/10.1056/NEJMoa0708857

Jul 24, 2008 ... Original Article from The New England Journal of Medicine — Sorafenib in Advanced Hepatocellular Carcinoma.

More Info

Sorafenib: MedlinePlus Drug Information

medlineplus.gov

Aug 15, 2016 ... Sorafenib: learn about side effects, dosage, special precautions, and more on MedlinePlus.

sorafenib oral : Uses, Side Effects, Interactions, Pictures, Warnings ...

www.webmd.com

Find patient medical information for sorafenib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Definition of sorafenib tosylate - NCI Drug Dictionary - National ...

www.cancer.gov

sorafenib tosylate: Patient Information: The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the ...